Elsevier MDL Unveils PharmaPendium(TM) -- A New Drug Safety Product.SAN RAMON, Calif. -- Elsevier MDL (NYSE NYSE See: New York Stock Exchange :RUK)(NYSE:ENL)(LSE LSE - Language Sensitive Editor :REL) is pleased to announce the release of PharmaPendium(TM) (www.pharmapendium.com), an essential drug safety resource that provides researchers with unprecedented access to an online collection of best-in-class drug safety content, including searchable FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval packages. "Drug safety is a pressing issue for the pharmaceutical industry, governmental regulators and our public health," said Lars Barfod, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Elsevier MDL. "Our customers tell us that PharmaPendium meets a clear need for efficient access to drug safety data and can help make an important difference in drug research." The concept for this resource was developed with input from various preclinical researchers utilizing drug safety in their daily work. Extensive input was also provided by the FDA under a Cooperative Research and Development Agreement “CRADA” redirects here. For other uses, see CRADA (disambiguation). A Cooperative Research and Development Agreement (CRADA) is an agreement between a government agency and a private company to work together. (CRADA CRADA Cooperative Research And Development Agreement ) between the FDA and MDL MDL - (Originally "Muddle"). C. Reeve, Carl Hewitt and Gerald Sussman, Dynamic Modeling Group, MIT ca. 1971. Intended as a successor to Lisp, and a possible base for Planner-70. Basically LISP 1.5 with data types and arrays. Information Systems. Dr. Edwin Matthews and Dr. Joseph Contrera, FDA's Center for Drug Evaluation and Research The Center for Drug Evaluation and Research is a division of the FDA that deals with the approval of drugs. CDER reviews New Drug Applications to ensure that the drugs are safe and effective. It is one of five Centers at the United States Food and Drug Administration. , Office of Pharmaceutical Science, are the FDA Investigators on the CRADA. "We believe this concept will be very useful to the scientific community and to our own research on the adverse effects and toxicological activities of pharmaceuticals. This resource could also be an important tool to facilitate the goals of the FDA's Critical Path Initiative (http://www.fda.gov/oc/initiatives/criticalpath/), and to support drug safety and drug development programs." PharmaPendium is the only product featuring searchable access to FDA Approval Packages. Researchers and information specialists no longer have to order relevant packages and spend weeks or months sifting through long documents looking for pertinent information. PharmaPendium provides a longitudinal view of preclinical, clinical and post-market safety data, which allows researchers to determine what observed effects in animals translate to humans for similar candidate compound drugs. In addition, the resource provides four pathways into drug safety information: by drug (class), by adverse effect/toxicity, by target and by chemical structure. PharmaPendium will help toxicologists, safety pharmacologists, drug safety team members and information specialists in the pharmaceutical sciences. Other key resources such as the Adverse Event Reporting System (AERS AERS Adverse Event Reporting System (database of drug adverse reactions) AERS Association of Educators in Radiological Sciences AERS Army Educational Requirements System AERS Acute Equine Respiratory Syndrome AERS Access/Egress Roadway System ), Meyler's Side Effects of Drugs and Drug monographs from Mosby's Drug Consult(TM) can be searched in seconds, saving hours for preclinical and clinical researchers. In addition, selected terminology from the Medical Dictionary for Regulatory Activities (MedDRA(R)) has been built into PharmaPendium to enhance intelligent searching and browsing of side effect content. As a knowledge database leader, Elsevier MDL is committed to providing pharmaceutical researchers with unprecedented access to essential drug safety information. About Elsevier MDL Elsevier MDL provides informatics, database and workflow solutions that accelerate successful life sciences R&D by improving the speed and quality of scientists' decision making. Researchers around the world depend on Elsevier MDL for innovative and reliable discovery informatics software solutions and services augmented by 400 Elsevier chemistry and life sciences journals and related products. For more information, visit www.mdl.com. Elsevier is a world-leading publisher of scientific, technical and medical information products and services. For more information visit www.elsevier.com. Elsevier is part of Reed Elsevier Group plc, a world-leading publisher and information provider. Reed Elsevier's ticker symbols are REN ren or jen In Confucianism, the most basic of all virtues, variously translated as “humaneness” or “benevolence.” It originally denoted the kindness of rulers to subjects. (Euronext Amsterdam), REL (London Stock Exchange London Stock Exchange London marketplace for securities. It was formed in 1773 by a group of stockbrokers who had been doing business informally in local coffeehouses. ), RUK and ENL (New York Stock Exchange New York Stock Exchange (NYSE) World's largest marketplace for securities. The exchange began as an informal meeting of 24 men in 1792 on what is now Wall Street in New York City. ). Notes to Editors: To learn more about PharmaPendium, contact your Elsevier MDL Account Manager, visit www.mdl.com or www.pharmapendium.com or send a message to pharmapendium@elsevier.com. Dr. Edwin Matthews (edwin.matthews@fda.hhs.gov) and Dr. Joseph Contrera (joseph.contrera@fda.hhs.gov) are the FDA Investigators on the CRADA. MDL and PharmaPendium are registered trademarks of MDL Information Systems, Inc. ('Elsevier MDL') in the United States. MedDRA is a registered trademark of the International Federation of Pharmaceutical Manufacturers Associations in the United States. Separate license to MedDRA required. Other names or products may be the trademarks or registered trademarks of their respective owners. All rights reserved. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion